Xie, J., Li, N., Jiang, X., Chai, L., Chen, J., & Deng, W. (2019). Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes.
Παραπομπή Chicago StyleXie, Jing, Ning Li, Xiaoyan Jiang, Liyin Chai, Jian-Jun Chen, και Wuquan Deng. "Short-term Efficacy and Safety of Repaglinide Versus Glimepiride As Augmentation of Metformin in Treating Patients With Type 2 Diabetes Mellitus." Diabetes Metab Syndr Obes 2019.
Παραπομπή MLAXie, Jing, et al. "Short-term Efficacy and Safety of Repaglinide Versus Glimepiride As Augmentation of Metformin in Treating Patients With Type 2 Diabetes Mellitus." Diabetes Metab Syndr Obes 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.